Erez Raphael - 11 Sep 2025 Form 4 Insider Report for DarioHealth Corp. (DRIO)

Role
Chief Executive Officer, Director
Signature
/s/ Erez Raphael
Issuer symbol
DRIO
Transactions as of
11 Sep 2025
Net transactions value
$0
Form type
4
Filing time
15 Sep 2025, 16:08:08 UTC
Previous filing
28 Aug 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Raphael Erez Chief Executive Officer, Director 322 W 57TH STREET, #33B, NEW YORK /s/ Erez Raphael 15 Sep 2025 0001668046

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DRIO Common Stock Award $0 +60,000 +62% $0.000000 156,853 11 Sep 2025 Direct F1, F2
holding DRIO Common Stock 1,894 11 Sep 2025 By Dicilyon Consulting and Investment Ltd. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted share award shall vest in two equal installments on the last day of each successive annual anniversary after the grant date over a two-year period.
F2 The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025.